Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 12 de 12
Filter
Add more filters










Publication year range
1.
J Child Neurol ; 28(2): 264-8, 2013 Feb.
Article in English | MEDLINE | ID: mdl-22532554

ABSTRACT

Prenatal diagnosis of disorders due to mitochondrial DNA (mtDNA) tRNA gene mutations is problematic. Experience in families harboring the protein-coding ATPase 6 m.8993T>G mutation suggests that the mutant load is homogeneous in different tissues, thus allowing prenatal diagnosis. We have encountered a novel protein-coding gene mutation, m.10198C>T in MT-ND3. A baby girl homoplasmic for this mutation died at 3 months after severe psychomotor regression and respiratory arrest. The mother had no detectable mutation in accessible tissues. The product of a second pregnancy showed only wild-type mt genomes in amniocytes, chorionic villi, and biopsied fetal muscle. This second girl is now 18 months old and healthy. Our observations support the concept that the pathogenic mutation in this patient appeared de novo and that fetal muscle biopsy is a useful aide in prenatal diagnosis.


Subject(s)
Fetal Growth Retardation , Mitochondrial Proton-Translocating ATPases/genetics , Mutation/genetics , Prenatal Diagnosis , Biopsy , Cytochromes c/metabolism , DNA Mutational Analysis , DNA, Mitochondrial , Family Health , Female , Fetal Growth Retardation/diagnosis , Fetal Growth Retardation/genetics , Fetal Growth Retardation/physiopathology , Humans , Infant , Male , Muscle, Skeletal/metabolism , Muscle, Skeletal/pathology , Pregnancy
2.
Anal Biochem ; 427(2): 202-10, 2012 Aug 15.
Article in English | MEDLINE | ID: mdl-22579594

ABSTRACT

Characterization of mitochondrial DNA (mtDNA) single nucleotide polymorphisms (SNPs) and mutations is crucial for disease diagnosis, which requires accurate and sensitive detection methods and quantification due to mitochondrial heteroplasmy. We report here the characterization of mutations for myoclonic epilepsy with ragged red fibers syndrome using chemically cleavable biotinylated dideoxynucleotides and a mass spectrometry (MS)-based solid phase capture (SPC) single base extension (SBE) assay. The method effectively eliminates unextended primers and primer dimers, and the presence of cleavable linkers between the base and biotin allows efficient desalting and release of the DNA products from solid phase for MS analysis. This approach is capable of high multiplexing, and the use of different length linkers for each of the purines and each of the pyrimidines permits better discrimination of the four bases by MS. Both homoplasmic and heteroplasmic genotypes were accurately determined on different mtDNA samples. The specificity of the method for mtDNA detection was validated by using mitochondrial DNA-negative cells. The sensitivity of the approach permitted detection of less than 5% mtDNA heteroplasmy levels. This indicates that the SPC-SBE approach based on chemically cleavable biotinylated dideoxynucleotides and MS enables rapid, accurate, and sensitive genotyping of mtDNA and has broad applications for genetic analysis.


Subject(s)
DNA Fingerprinting/methods , DNA, Mitochondrial/analysis , Dideoxynucleotides/chemistry , MERRF Syndrome/genetics , Mitochondria/genetics , Polymorphism, Single Nucleotide , Base Sequence , Biotin/chemistry , Biotinylation , Cell Line , Dideoxynucleotides/genetics , Humans , MERRF Syndrome/diagnosis , Mitochondria/chemistry , Molecular Sequence Data , Mutation , Polymerase Chain Reaction , Purines/chemistry , Pyrimidines/chemistry , Sensitivity and Specificity , Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization , Streptavidin/chemistry
3.
J Exp Integr Med ; 2(2)2012.
Article in English | MEDLINE | ID: mdl-24265579

ABSTRACT

The human mitochondrial genome is replicated by DNA polymerase γ, which is encoded by polymerase γ gene (POLG1) on chromosome 15q25. Patients with POLG1 mutations usually present as Alpers' syndrome or progressive external ophthalmoplegia. Our patient was a 48-year old woman with sensory ataxic neuropathy, dysarthria, ophthalmoplegia, and dysphagia. Sequence analysis revealed that she has two heterozygous missense mutations in the POLG1, a c.1774C>T substitution in exon 10, which results in a p.L591F amino acid change; and a c.3286C>T substitution in exon 21, which results in a p.R1096C amino acid change. The 1774C>T substitution is a novel mutation. Previously described adult patients with one mutation in exon 10 and the other in exon 21 of POLG1 had presented with progressive external ophthalmoplegia. We now describe a patient with mutations in the same exons but suffering from the more complex clinical syndrome of sensory ataxic neuropathy, dysarthria, ophthalmoplegia.

4.
Mol Genet Metab ; 95(1-2): 31-8, 2008.
Article in English | MEDLINE | ID: mdl-18676167

ABSTRACT

Pyruvate carboxylase (PC) deficiency (OMIM, 266150) is a rare autosomal recessive disease. The revised PC gene structure described in this report consists of 20 coding exons and four non-coding exons at the 5'-untranslated region (5'-UTR). The gene codes for three transcripts due to alternative splicing: variant 1 (NM_000920.3), variant 2 (NM_022172.2) and variant 3 (BC011617.2). PC deficiency is manifested by three clinical phenotypes-an infantile form (Type A), a neonatal form (Type B), and a benign form (Type C). We report the molecular basis for eight cases (one Type A, five Type B and two Type C) of PC deficiency. Eight novel complex mutations were identified representing different combinations of missense mutations, deletions, a splice site substitution and a nonsense mutation. The classical phenotypes (A, B and C) correlated poorly with clinical outcomes. Mosaicism was found in five cases (one Type A, three Type B and one Type C) and four of these cases had prolonged survival. Death in the fifth case resulted from unrelated medical complications. The discrepancy between the current findings and the existing classification system should be addressed to accommodate these new observations.


Subject(s)
Mosaicism , Pyruvate Carboxylase Deficiency Disease/genetics , Pyruvate Carboxylase/genetics , Survival , Adolescent , Adult , Alternative Splicing , Cells, Cultured , Child , Child, Preschool , Exons , Female , Humans , Infant , Infant, Newborn , Male , Mutation , Polymorphism, Restriction Fragment Length , Pyruvate Carboxylase/metabolism , Pyruvate Carboxylase Deficiency Disease/enzymology , Pyruvate Carboxylase Deficiency Disease/mortality
5.
J Neurol Sci ; 270(1-2): 23-7, 2008 Jul 15.
Article in English | MEDLINE | ID: mdl-18314141

ABSTRACT

Mitochondrial encephalopathy, lactic acidosis and stroke-like episodes (MELAS) is the most common mitochondrial disease due to mitochondrial DNA (mtDNA) mutations. At least 15 distinct mtDNA mutations have been associated with MELAS, and about 80% of the cases are caused by the A3243G tRNA(Leu(UUR)) gene mutation. We report here a novel tRNA(Val) mutation in a 37-year-old woman with manifestations of MELAS, and compare her clinicopathological phenotype with other rare cases associated tRNA(Val) mutations.


Subject(s)
DNA, Mitochondrial/genetics , MELAS Syndrome/genetics , Mutation , RNA, Transfer, Val/genetics , Adult , Brain/pathology , DNA Mutational Analysis/methods , Female , Humans , MELAS Syndrome/pathology , Magnetic Resonance Imaging/methods , Magnetic Resonance Spectroscopy/methods , Muscle, Skeletal/pathology
6.
Arch Neurol ; 65(3): 368-72, 2008 Mar.
Article in English | MEDLINE | ID: mdl-18332249

ABSTRACT

BACKGROUND: The number of molecular causes of MELAS (a syndrome consisting of mitochondrial encephalomyopathy, lactic acidosis, and strokelike episodes) and Leigh syndrome (LS) has steadily increased. Among these, mutations in the ND5 gene (OMIM 516005) of mitochondrial DNA are important, and the A13513A change has emerged as a hotspot. OBJECTIVE: To describe the clinical features, muscle pathological and biochemical characteristics, and molecular study findings of 12 patients harboring the G13513A mutation in the ND5 gene of mitochondrial DNA compared with 14 previously described patients with the same mutation. DESIGN: Clinical examinations and morphological, biochemical, and molecular analyses. SETTING: Tertiary care university hospital and molecular diagnostic laboratory. PATIENTS: Three patients had the typical syndrome features of MELAS; the other 9 had typical clinical and radiological features of LS. RESULTS: Family history suggested maternal inheritance in a few cases; morphological studies of muscle samples rarely showed typical ragged-red fibers and more often exhibited strongly succinate dehydrogenase-reactive blood vessels. Biochemically, complex I deficiency was inconsistent and generally mild. The mutation load was relatively high in the muscle and blood specimens. CONCLUSION: The G13513A mutation is a common cause of MELAS and LS, even in the absence of obvious maternal inheritance, pathological findings in muscle, or severe complex I deficiency.


Subject(s)
DNA, Mitochondrial/genetics , Electron Transport Complex I/genetics , Leigh Disease/genetics , MELAS Syndrome/genetics , Mitochondrial Proteins/genetics , Mutation/genetics , Adult , Child, Preschool , DNA Mutational Analysis , Electron Transport Complex IV/metabolism , Family Health , Female , Humans , Infant , Leigh Disease/pathology , MELAS Syndrome/pathology , Male , Middle Aged , Muscle, Smooth, Vascular/metabolism , Succinate Dehydrogenase/metabolism
7.
J Neurol Sci ; 254(1-2): 17-21, 2007 Mar 15.
Article in English | MEDLINE | ID: mdl-17257622

ABSTRACT

We report a novel missense mutation (Asp109Tyr) in exon 4 of the Cu/Zn superoxide dismutase (sod1) gene in a woman with apparently sporadic amyotrophic lateral sclerosis (SALS). Signs of motor deficit appeared at the age of 51 years which progressed over the next 6 years to upper and lower motor neuron disease and death occurred by the age of 57 years. In this mutation, the base change of guanine to thymine at codon 109 of sod1 gene leads to the replacement of aspartic by tyrosine in the protein. This amino acid change in the protein however, did not alter the catalytic activity of the SOD1 enzyme as there was no change in the enzymatic activity of purified SOD1 from the patient's erythrocytes compared to control.


Subject(s)
Amyotrophic Lateral Sclerosis/enzymology , Amyotrophic Lateral Sclerosis/genetics , Central Nervous System/enzymology , Genetic Predisposition to Disease/genetics , Mutation, Missense/genetics , Superoxide Dismutase/genetics , Amino Acid Substitution/genetics , Aspartic Acid/genetics , Base Sequence/genetics , Catalytic Domain/genetics , Central Nervous System/pathology , Central Nervous System/physiopathology , Codon/genetics , DNA Mutational Analysis , Disease Progression , Fatal Outcome , Female , Genetic Markers/genetics , Genotype , Humans , Middle Aged , Tyrosine/genetics
8.
Muscle Nerve ; 34(5): 572-6, 2006 Nov.
Article in English | MEDLINE | ID: mdl-16881065

ABSTRACT

We report two patients in whom phosphoglycerate mutase (PGAM) deficiency was associated with the triad of exercise-induced cramps, recurrent myoglobinuria, and tubular aggregates in the muscle biopsy. Serum creatine kinase (CK) levels were elevated between attacks of myoglobinuria. Forearm ischemic exercise tests produced subnormal increases of venous lactate. Muscle biopsies showed subsarcolemmal tubular aggregates in type 2 fibers. Muscle PGAM activities were markedly decreased (3% of the normal mean) and molecular genetic studies showed that both patients were homozygous for a described missense mutation (W78X). A review of 15 cases with tubular aggregates in the muscle biopsies from our laboratory and 15 cases with PGAM deficiency described in the literature showed that this clinicopathological triad is highly suggestive of PGAM deficiency.


Subject(s)
Exercise Tolerance/genetics , Muscle, Skeletal/enzymology , Muscular Diseases/enzymology , Myoglobinuria/enzymology , Phosphoglycerate Mutase/deficiency , Adolescent , Adult , Black or African American/genetics , Biopsy , Creatine Kinase/blood , DNA Mutational Analysis , Exercise Test , Female , Humans , Inclusion Bodies/enzymology , Inclusion Bodies/genetics , Inclusion Bodies/pathology , Ischemia/enzymology , Ischemia/genetics , Ischemia/physiopathology , Male , Middle Aged , Muscle Cramp/enzymology , Muscle Cramp/genetics , Muscle Cramp/physiopathology , Muscle, Skeletal/pathology , Muscle, Skeletal/physiopathology , Muscular Diseases/diagnosis , Muscular Diseases/genetics , Mutation, Missense , Myoglobinuria/genetics , Myoglobinuria/physiopathology , Phosphoglycerate Mutase/genetics , Sarcoplasmic Reticulum/enzymology , Sarcoplasmic Reticulum/pathology
9.
Arch Neurol ; 62(3): 473-6, 2005 Mar.
Article in English | MEDLINE | ID: mdl-15767514

ABSTRACT

BACKGROUND: The mitochondrial DNA gene encoding subunit 5 of complex I (ND5) has turned out to be a hot spot for mutations associated with mitochondrial encephalomyopathy with lactic acidosis and strokelike episodes (MELAS) and various overlap syndromes. OBJECTIVE: To describe a novel mutation in the ND5 gene in a young man man with an overlap syndrome of MELAS and myoclonus epilepsy with ragged-red fibers. DESIGN: Case report. PATIENT: A 25-year-old man had recurrent strokes, seizures, and myoclonus. His mother also had multiple strokes. A muscle biopsy specimen showed no ragged-red fibers but several strongly succinate dehydrogenase-reactive blood vessels. RESULTS: Biochemical analysis showed isolated complex I deficiency and molecular analysis revealed a novel heteroplasmic mutation (G13042A) in the ND5 gene. CONCLUSIONS: These data confirm that ND5 is a genetic hot spot for overlap syndromes, including MELAS and strokelike and myoclonus epilepsy with ragged-red fibers.


Subject(s)
DNA, Mitochondrial/genetics , Electron Transport Complex I/genetics , MELAS Syndrome/genetics , MERRF Syndrome/genetics , Mutation , Protein Subunits/genetics , Adult , Amino Acid Sequence , Humans , MELAS Syndrome/enzymology , MELAS Syndrome/pathology , MERRF Syndrome/enzymology , MERRF Syndrome/pathology , Male , Mitochondrial Proteins , Molecular Sequence Data , Succinate Dehydrogenase/genetics , Succinate Dehydrogenase/metabolism
10.
J Child Neurol ; 20(2): 142-6, 2005 Feb.
Article in English | MEDLINE | ID: mdl-15794182

ABSTRACT

The majority of patients with MELAS (mitochondrial encephalomyopathy, lactic acidosis, and strokelike episodes) have the A3243G point mutation. The much rarer T3271C mutation has been reported predominantly in Japanese subjects. Our objective was to better define the clinical phenotype and mutation load in patients with MELAS and the T3271C mutation in mitochondrial DNA. We present clinical and molecular genetic data in two pedigrees with the T3271C mutation. The age at onset was 8 years in one proband and 14 years in the other. Both patients had migrainelike headache, seizures, and strokelike episodes. Mutation loads were quantified in multiple tissues from the patients and from family members by polymerase chain reaction-restriction fragment length polymorphism analysis. The symptoms in both probands were typical of MELAS, and, contrary to previous reports, onset was early. Hearing loss was less common than in typical MELAS, and ragged red fibers were absent. The proportion of mutant genomes was consistently and markedly greater in DNA from urinary sediment than from blood. In the mother of one proband, mutant genomes were detected only in DNA from hair follicles and cheek mucosa The phenotype of patients with the T3271C mutation might not be as distinct as that of the A3243G mutation, as previously described. Our data also suggest that urine is a better source of DNA than blood for diagnosis and that multiple tissues should be studied in maternal relatives, especially when the mutation cannot be detected in blood.


Subject(s)
DNA, Mitochondrial/genetics , MELAS Syndrome/genetics , Point Mutation/genetics , Adolescent , Age of Onset , Brain/pathology , Child , Female , Humans , MELAS Syndrome/complications , MELAS Syndrome/pathology , Male , Muscle, Skeletal/pathology , Pedigree , Phenotype
11.
Am J Med Genet A ; 130A(2): 134-7, 2004 Oct 01.
Article in English | MEDLINE | ID: mdl-15372523

ABSTRACT

Testing for common mutations in mitochondrial DNA (mtDNA), including the A3243G MELAS (mitochondrial encephalomyopathy, lactic acidosis, and strokelike episodes) mutation, is routinely done in DNA isolated from blood. Since the blood level of the A3243G mutation may be low in probands and even lower in asymptomatic or oligosymptomatic maternal relatives, we assessed the proportion of A3243G mutant genomes in other accessible tissues. We studied five tissues (leukocytes, skin fibroblasts, hair roots, urinary sediment, and cheek mucosa) in 61 individuals from 22 families harboring the A3243G mutation. Although mutational loads varied widely among these tissues, as a rule DNA from urinary sediment had the highest and blood the lowest proportion of mutant genomes; individual hair roots differed markedly from one another; fibroblasts and cheek mucosa tended to have higher mutation loads than blood but lower than urinary sediment. In all individuals in whom the mutation was detectable in blood, it was also detected in other tissues. Conversely, in some individuals the mutation was undetectable in blood but clearly present in other tissues. We conclude that urinary sediment and cheek mucosa are tissues of choice for the diagnosis of mtDNA mutations, as they are easy to obtain and the mutation load is almost always greater than in blood.


Subject(s)
DNA, Mitochondrial/genetics , Point Mutation , DNA Mutational Analysis , DNA, Mitochondrial/blood , DNA, Mitochondrial/urine , Family Health , Female , Fibroblasts/metabolism , Hair/metabolism , Humans , MELAS Syndrome/diagnosis , MELAS Syndrome/genetics , Male , Mucous Membrane/metabolism , Pedigree
12.
Headache ; 44(7): 674-7, 2004.
Article in English | MEDLINE | ID: mdl-15209689

ABSTRACT

Ten patients with migraine with prolonged aura were studied for the presence of mitochondrial DNA point mutations utilizing DNA isolated from blood and hair samples. We analyzed for nine point mutations reported in patients with MELAS (A3243G, C3256T, T3271C, T3291C, A5814G, T8356C, T9957C, G13513A, and A13514G) and three secondary LHON mutations (T4216C, A4917G, and G13708A). None of the patients tested had any of these mutations in mitochondrial DNA. However, one patient was found to have a tRNA(Gln) A4336G mitochondrial DNA variant. From this study it appears that migraine with prolonged aura is not an oligosymptomatic form of MELAS and is not related to secondary LHON mutations. The significance of the tRNA A4336G variant is unknown.


Subject(s)
DNA, Mitochondrial/genetics , Migraine with Aura/genetics , Point Mutation , Base Sequence , Humans , Migraine with Aura/pathology , RNA, Transfer, Gln/genetics , Time Factors
SELECTION OF CITATIONS
SEARCH DETAIL
...